ADOPTIVE IMMUNOTHERAPY WITH LYMPHOKINE-ACTIVATED KILLER CELLS PLUS RECOMBINANT INTERLEUKIN-2 IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR-CARCINOMA

被引：41
|
作者：
ONISHI, S
SAIBARA, T
FUJIKAWA, M
SAKAEDA, H
MATSUURA, Y
MATSUNAGA, Y
YAMAMOTO, Y
机构：
来源：
HEPATOLOGY | 1989年 / 10卷 / 03期
关键词：
D O I：
10.1002/hep.1840100318
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：349 / 353
页数：5
相关论文
共 50 条
  • [1] ADOPTIVE IMMUNOTHERAPY WITH LYMPHOKINE ACTIVATED KILLER CELLS PLUS RECOMBINANT INTERLEUKIN-2 IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR-CARCINOMA
    ONISHI, S
    SAIBARA, T
    SAKAEDA, H
    MATSUURA, Y
    FUJIKAWA, M
    MATSUNAGA, Y
    IDO, A
    IWAMURA, S
    TOMITA, T
    YAMAMOTO, Y
    HEPATOLOGY, 1988, 8 (05) : 1287 - 1287
  • [2] IMMUNOTHERAPY OF HEPATOCELLULAR-CARCINOMA WITH AUTOLOGOUS LYMPHOKINE-ACTIVATED KILLER CELLS AND OR RECOMBINANT INTERLEUKIN-2
    ISHIKAWA, T
    IMAWARI, M
    MORIYAMA, T
    OHNISHI, S
    MATSUHASHI, N
    SUZUKI, G
    TAKAKU, F
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1988, 114 (03) : 283 - 290
  • [3] IMMUNOTHERAPY OF HEPATOCELLULAR-CARCINOMA WITH RECOMBINANT INTERLEUKIN-2 AND OR AUTOLOGOUS LYMPHOKINE-ACTIVATED KILLER-CELLS
    ISHIKAWA, T
    MORIYAMA, T
    OHNISHI, S
    MATSUHASHI, N
    IMAWARI, M
    TAKAKU, F
    JOURNAL OF MEDICAL VIROLOGY, 1987, 21 (04) : A113 - A114
  • [4] TREATMENT OF HEPATOCELLULAR-CARCINOMA UTILIZING LYMPHOKINE-ACTIVATED KILLER CELLS AND INTERLEUKIN-2
    ICHIDA, T
    HIGUCHI, K
    ARAKAWA, K
    OHTA, H
    SUGIYAMA, K
    MIYAGIWA, M
    NOHZAWA, A
    SATOH, T
    SASAKI, H
    ICHIDA, F
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 23 : S45 - S48
  • [5] LABORATORY CORRELATES OF ADOPTIVE IMMUNOTHERAPY WITH RECOMBINANT INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS IN HUMANS
    BOLDT, DH
    MILLS, BJ
    GEMLO, BT
    HOLDEN, H
    MIER, J
    PAIETTA, E
    MCMANNIS, JD
    ESCOBEDO, LV
    SNIECINSKI, I
    RAYNER, AA
    HAWKINS, MJ
    ATKINS, MB
    CIOBANU, N
    ELLIS, TM
    CANCER RESEARCH, 1988, 48 (15) : 4409 - 4416
  • [6] IMMUNOTHERAPY OF CANCER WITH LYMPHOKINE-ACTIVATED KILLER CELLS AND RECOMBINANT INTERLEUKIN-2
    ROSENBERG, SA
    MULE, JJ
    SURGERY, 1985, 98 (03) : 437 - 444
  • [7] INTERSTITIAL NEPHRITIS IN A PATIENT RECEIVING ADOPTIVE IMMUNOTHERAPY WITH RECOMBINANT INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS
    FEINFELD, DA
    DAGATI, V
    DUTCHER, JP
    WERFEL, SB
    LYNN, RI
    WIERNIK, PH
    AMERICAN JOURNAL OF NEPHROLOGY, 1991, 11 (06) : 489 - 492
  • [8] TOXICITY OF IMMUNOTHERAPY WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS
    MIER, JW
    ARONSON, FR
    NUMEROF, RP
    VACHINO, G
    ATKINS, MB
    PATHOLOGY AND IMMUNOPATHOLOGY RESEARCH, 1988, 7 (06): : 459 - 476
  • [9] INTRATUMORAL ECHO-GUIDED INJECTION OF INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS IN HEPATOCELLULAR-CARCINOMA
    GANDOLFI, L
    SOLMI, L
    PIZZA, GC
    BERTONI, F
    MURATORI, R
    DEVINCI, C
    BACCHINI, P
    MORELLI, MC
    CORRADO, G
    HEPATO-GASTROENTEROLOGY, 1989, 36 (05) : 352 - 356
  • [10] REGIONAL ADOPTIVE IMMUNOTHERAPY WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS FOR LIVER METASTASES
    KEILHOLZ, U
    SCHEIBENBOGEN, C
    BRADO, M
    GEORGI, P
    MACLACHLAN, D
    BRADO, B
    HUNSTEIN, W
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (01) : 103 - 105
12345